Skip to main content
. 2017 Mar 15;8(26):42359–42371. doi: 10.18632/oncotarget.16218

Figure 7. Tumor progression and survival analysis.

Figure 7

(A) Comparison of tumor progression, represented by luminescence intensity detected by the IVIS after the sham procedure (n=4), IV administration of 50uL of Dox-MB (IV Dox-MB; n = 5) and Dox-MB infusion through CED at concentrations 0.1 mg/mL (CED Dox-MB, low; n = 5) and 0.5 mg/mL (CED Dox-MB, high; n = 5). (B) Corresponding Kaplan–Meier plot showing animal survival improvement from CED of Dox-MB. Arrow indicates the date to implant tumor cells into animals.